REN and diabetic kidney disease: In this study we investigated the effect of GLP-1R agonist liraglutide on blood pressure, hydration status, natriuresis and the activity of the renin–angiotensin–aldosterone axis in patients with diabetic kidney disease after a dose of liraglutide compared to placebo.